• Enhancing insulin secretion and promoting glycemic control
• Reducing appetite and promoting satiety
• Increasing targeted fat metabolism
• In addition to reductions in body weight, abdominal fat and liver fat, Retatrutide treatment has been associated with improvements in insulin sensitivity, lipid metabolism and adipocyte hormones

• Significant weight loss
• Improved glycemic control and insulin sensitivity
• Reduced appetite and cravings
• Enhanced fat metabolism
• Lower risk of heart disease, such as heart failure, stroke and kidney disease
• Better overall metabolic health and reduced risk of obesity-related conditions

The onset of effects varies among individuals. Some may notice changes within a few weeks, while others might take a couple of months to observe significant improvements.

Common side effects include:

• Nausea and vomiting
• Diarrhea or constipation
• Mild injection site reactions
• Headaches

Remember, everyone reacts differently to peptide therapy due to individual physiological differences such as metabolism rate and overall health status. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away. Tell your doctor if you have any side effects.

Lyophilized powder is a freeze-dried powder. The shelf life of peptide solutions (commonly cold shipped) is far less than that of lyophilized peptides, and peptides stored in solution are also vulnerable to bacterial degradation.

When storing lyophilized peptides for months or even years, freezing is optimal in order to preserve the peptide’s stability. After opening or reconstituting a peptide with Bacteriostatic Water, peptide solutions are generally stable for up to 45 days when refrigerated at 4C (39F).

If you need instructions to reconstitute your peptide, schedule a wellness consultation.

All compounded drugs, medications, and peptides for clinical research are not FDA-approved. In some cases, they can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product. For example, a patient may be unable to swallow a pill or may have an allergy to an inactive ingredient in an FDA-approved drug. Always check local regulations and consult with a healthcare professional before using peptides.

There are currently three FDA-approved Semaglutide products:

• Ozempic® and RYBELSUS® for adults with type 2 diabetes mellitus
• Wegovy® is approved to help adults and children aged 12 years and older with obesity or some adults with excess weight (overweight), who also have weight-related medical problems.

There are currently two FDA-approved Tirzepatide products:

• Mounjaro® and Zepbound® made by Eli Lilly are the only FDA-approved Tirzepatide medications for the treatment of type 2 diabetes. It is also being studied for weight loss, but it is not yet FDA-approved specifically for this indication.
• These medications are not approved for – and should not be used for – cosmetic weight loss.

AOD-9604 is not FDA-approved for weight loss or any other medical condition. It is available for research purposes and is sometimes used off-label.

Retatrutide is currently in the research phase and is not FDA-approved for weight loss or any other medical condition. Clinical trials are ongoing to assess its efficacy and safety.

We're happy to help answer questions you may have, or refer you to a licensed healthcare professional for medical advice. Email us at care@somapeptides.com or schedule a wellness consultation.